View Notice

GARDINER & THEOBALD LLP

Cancer Centre Development Chelsea

Publication Platform
GARDINER & THEOBALD LLP

Publication Date
17 June 2022

Deadline
5:00pm, 18 July 2022

Tender ID
RMH001

Description
The project is the Cancer Centre development of The Royal Marsden's Chelsea Estate and involves a significant proportion of the Royal Marsden's site on the Fulham Road. To ensure that The Royal Marsden is well equipped to continue improving cancer survival for its patients, the hospital's next major priority is to improve and develop its Chelsea site. The hospital strives to be at the forefront of introducing leading cutting-edge research advances to patients, an idea that was core to the concept behind the Oak Cancer Centre at Sutton which is currently under construction. The aim for Chelsea is to create a centre that will allow us to integrate the latest research advances into the whole patient journey - from diagnosis, through treatment, to living with and beyond cancer. This ambitious plan will seek to significantly add to our current Royal Marsden buildings and will be split across two phases. We require an architect to design both phases with an expectation of work up to RIBA stage 2 across both phases, before the focus shifts to phase 1 for the more detailed design stages. We will then seek to progress the design of phase 2 at a suitable time, but likely not before construction on phase 1 is underway. Please download the NDA and return to Gardiner & Theobald to obtain SQ document.